Demant CEO says wave of hearing aid launches won’t upset customer behavior

All major hearing aid makers are launching new premium devices at the same time, but Søren Nielsen expects audiologists to choose suppliers as usual and average selling prices to rise.

Continue reading at MedWatch

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — this is an executive market commentary with no clinical or practice-management implication for individual audiologists.

✦ Why It Matters ✦

Signals that major manufacturers expect premium-tier pricing to hold even amid simultaneous product launches, which could shape procurement costs and dispensing margins for clinic owners.

✦ Key Points ✦

01Demant CEO Søren Nielsen does not expect simultaneous premium launches to disrupt audiologist purchasing behavior.
02Nielsen forecasts average selling prices (ASPs) for hearing aids will increase.
03The comment reflects broader industry confidence in premium-segment stability despite heightened competition.
04Insight is based on executive opinion, not market data or independent analysis.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Simultaneous premium hearing aid launches by major manufacturers will not disrupt audiologist purchasing behavior.

quoteunclear

Average selling prices for hearing aids are expected to increase.

quoteunclear

✦ Related stories ✦

PubMed·Clinical trial·Hearing aids·7w ago

Unilateral and Bilateral Hearing Aids for Age-Related Hearing Loss: A Randomized Clinical Trial

of this RCT directly bear on bilateral vs. unilateral fitting decisions for adults with symmetrical mild-to-moderate age-related hearing loss; full-text review is essential, but this is potentially practice-changing depending on the direction and magnitude of the findings.

PubMed·Journal article·Hearing aids·7w ago

Hearing aids for mild to moderate hearing loss in adults

Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.

PubMed·Journal article·Hearing aids·3mo ago

Digital Interventions for First-Time Hearing Aid Users: A Systematic Review and Meta-Analysis of Efficacy and Effectiveness

Clinicians should consider incorporating evidence-based digital support tools (apps, online programmes) into onboarding protocols for first-time hearing aid users, pending the meta-analysis's specific effect-size findings.

PubMed·Journal article·Hearing aids·3w ago

Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The meta-analytic findings on self-fitting vs. professional-fitting outcomes should prompt audiologists to review their value proposition and counsel patients on where professional fitting adds measurable benefit, particularly for complex hearing profiles.

PubMed·Journal article·Hearing aids·4mo ago

Individuals with near-normal audiograms but perceived hearing difficulties can achieve aided outcomes on par with those of peers with mild hearing loss

Audiologists should consider fitting hearing aids for patients with near-normal audiograms who report significant hearing difficulty, as aided outcomes can match those of patients with confirmed mild hearing loss.

PubMed·Journal article·Hearing aids·3mo ago

The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias

If the study shows hearing-aid use reduces Alzheimer's-related plasma biomarkers, it would strengthen the case for early hearing rehabilitation as a potential dementia-prevention strategy, though findings should be weighed by sample size and study design before changing practice.

PubMed·Journal article·Hearing aids·5mo ago

Hearing Aid Efficacy-Timely Trial Finds Professional Guidance Trumps Costly Tech

This trial supports prioritising high-quality audiological fitting and counselling over premium hearing aid technology alone — audiologists should emphasise their professional value proposition when discussing device options with patients.